Recent advances in the molecular biology and immunobiology of chronic lymphocytic leukemia

Seminars in Hematology

Volumn 41, Issue 3, 2004, Pages 207-223

  Ferrarini, Manlio ^a   Chiorazzi, Nicholas ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ANTIGEN PRESENTATION; APOPTOSIS; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CELL SURFACE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; GENETICS; HUMAN; IMMUNOBIOLOGY; IMMUNOCOMPETENT CELL; LEUKEMIA CELL; MOLECULAR BIOLOGY; MOLECULAR EVOLUTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TELOMERE;

EID: 3242698004     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2004.05.003     Document Type: Article

References (155)

1. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K., Cleary M.L., et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1994. Blood. 84:1994;1361-1392
2. Harris N.L., Jaffe E.S., Diebold J., Flandrin G., Muller-Hermelink H.K., Vardiman J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 17:1999;3835-3849
3. Matutes E., Owusu-Ankomah K., Morilla R., Garcia Marco J., Houlihan A., Que T.H., et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 8:1994;1640-1645
4. Rai K.R., Patel D.V. Chronic lymphocytic leukemia. Hoffman R., Benz E., Shattil S., Furie B., Cohen H., Silberstein L. Hematology Basic Principles and Practice. 1995;1308-1321 Churchill Livingstone, New York, NY
5. Chiorazzi N., Ferrarini M. B cell chronic lymphocytic leukemia Lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol. 21:2003;841-894
6. Shanafelt T.D., Geyer S.M., Kay N.E. Prognosis at diagnosis Integrating molecular biologic insights into clinical practice for patients with CLL. Blood. 103:2004;1202-1210
7. Rai K.R., Sawitsky A., Cronkite E.P., Chanana A.D., Levy R.N., Pasternack B.S. Clinical staging of chronic lymphocytic leukemia. Blood. 46:1975;219-234
8. Rai K. A critical analysis of staging in CLL. Gail R., Rai K. Chronic Lymphocytic Leukemia. Recent Progress and Future Directions. 1987;253-260 Liss, New York, NY
9. Binet J.L., Auquier A., Dighiero G., Chastang C., Piguet H., Goasguen J., et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 48:1981;198-206
10. Schroeder H.W. Jr, Dighiero G. The pathogenesis of chronic lymphocytic leukemia Analysis of the antibody repertoire. Immunol Today. 15:1994;288-294
11. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L., et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 102:1998;1515-1525
12. Ghiotto F., Fais F., Albesiano E., Gaidano G., Allen S.L., Kolitz J.E., et al. The light chain variable region gene repertoire of chronic lymphocytic leukemia B cells. J Clin Invest. 113:2004;1008-1016
13. Damle R.N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S.L., et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 94:1999;1840-1847
14. Hamblin T.J., Davis Z., Gardiner A., Oscier D.G., Stevenson F.K. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 94:1999;1848-1854
15. Maloum K., Davi F., Merle-Beral H., Pritsch O., Magnac C., Vuillier F., et al. Expression of unmutated VH genes is a detrimental prognotic factor in chronic lymphocytic leukemia. Blood. 96:2000;377-379
16. Krober A., Seiler T., Benner A., Bullinger L., Bruckle E., Lichter P., et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 100:2002;1410-1416
17. Lin K., Sherrington P.D., Dennis M., Matrai Z., Cawley J.C., Pettitt A.R. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood. 100:2002;1404-1409
18. Oscier D.G., Gardiner A.C., Mould S.J., Glide S., Davis Z.A., Ibbotson R.E., et al. Multivariate analysis of prognostic factors in CLL Clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood. 100:2002;1177-1184
19. Zupo S., Isnardi L., Megna M., Massara R., Malavasi F., Dono M., et al. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood. 88:1996;1365-1374
20. Ghia P., Guida G., Stella S., Gottardi D., Geuna M., Strola G., et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood. 101:2003;1262-1269
21. Hamblin T.J., Orchard J.A., Ibbotson R.E., Davis Z., Thomas P.W., Stevenson F.K., et al. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood. 99:2002;1023-1029
22. Chan A.C., Iwashima M., Turck C.E., Weiss A. ZAP-70 A 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell. 71:1992;649-662
23. Rosenwald A., Alizadeh A.A., Widhopf G., Simon R., Davis R.E., Yu X., et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 194:2001;1639-1647
24. Chen L., Widhopf G., Huynh L., Rassenti L., Rai K.R., Weiss A., et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 100:2002;4609-4614
25. Wiestner A., Rosenwald A., Barry T.S., Wright G., Davis R.E., Henrickson S.E., et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 101:2003;4944-4951
26. Crespo M., Bosch F., Villamor N., Bellosillo B., Colomer D., Rozman M., et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med. 348:2003;1764-1775
27. Orchard J.A., Ibbotson R.E., Davis Z., Wiestner A., Rosenwald A., Thomas P.W., et al. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet. 363:2004;105-111
28. MacLennan I.C., Liu Y.J., Oldfield S., Zhang J., Lane P.J. The evolution of B-cell clones. Curr Top Microbiol Immunol. 159:1990;37-63
29. Weller S., Faili A., Garcia C., Braun M.C., Le Deist F.F., de Saint Basile G.G., et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci USA. 98:2001;1166-1170
30. William J., Euler C., Christensen S., Shlomchik M.J. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science. 297:2002;2066-2070
31. Johnson T.A., Rassenti L.Z., Kipps T.J. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 158:1997;235-246
32. Ghiotto F., Fais F., Valetto A., Albesiano E., Hashimoto S., Dono M., et al. Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest. 113:2004;1008-1016
33. Tobin G., Thunberg U., Johnson A., Thorn I., Soderberg O., Hultdin M., et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood. 99:2002;2262-2264
34. Tobin G., Thunberg U., Johnson A., Eriksson I., Soderberg O., Karlsson K., et al. Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vλ2-14 gene use and homologous CDR3s Implicating recognition of a common antigen epitope. Blood. 101:2003;4952-4957
35. Messmer B.T., Albesiano E., Efremov D.G., Ghiotto F., Allen S.L., Kolitz J., et al. Multiple distinct sets of stereotyped antigen receptors suggest a key promoting role for antigen in chronic lymphocytic leukemia. J Exp Med. 2004;. (in press)
36. Diaw L., Magnac C., Pritsch O., Buckle M., Alzari P.M., Dighiero G. Structural and affinity studies of IgM polyreactive natural autoantibodies. J Immunol. 158:1997;968-976
37. Dighiero G., Rose N.R. Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity. Immunol Today. 20:1999;423-428
38. Briles D.E., Nahm M., Schroer K., Davie J., Baker P., Kearney J., et al. Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med. 153:1981;694-705
39. Ochsenbein A.F., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., et al. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 286:1999;2156-2159
40. Broker B.M., Klajman A., Youinou P., Jouquan J., Worman C.P., Murphy J., et al. Chronic lymphocytic leukemic cells secrete multispecific autoantibodies. J Autoimmun. 1:1988;469-481
41. Sthoeger Z.M., Wakai M., Tse D.B., Vinciguerra V.P., Allen S.L., Budman D.R., et al. Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med. 169:1989;255-268
42. Borche L., Lim A., Binet J.L., Dighiero G. Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood. 76:1990;562-569
43. Silverman G.J., Goldfien R.D., Chen P., Mageed R.A., Jefferis R., Goni F., et al. Idiotypic and subgroup analysis of human monoclonal rheumatoid factors. Implications for structural and genetic basis of autoantibodies in humans. J Clin Invest. 82:1988;469-475
44. Stevenson F.K., Longhurst C., Chapman C.J., Ehrenstein M., Spellerberg M.B., Hamblin T.J., et al. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus. J Autoimmun. 6:1993;809-825
45. Pugh-Bernard A.E., Silverman G.J., Cappione A.J., Villano M.E., Ryan D.H., Insel R.A., et al. Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. J Clin Invest. 108:2001;1061-1070
46. Silverman G.J., Roben P., Bouvet J.P., Sasano M. Superantigen properties of a human sialoprotein involved in gut-associated immunity. J Clin Invest. 96:1995;417-426
47. Li Y., Spellerberg M.B., Stevenson F.K., Capra J.D., Potter K.N. The I binding specificity of human VH 4-34 (VH 4-21) encoded antibodies is determined by both VH framework region 1 and complementarity determining region 3. J Mol Biol. 256:1996;577-589
48. Hivroz C., Geny B., Brouet J.C., Grillot-Courvalin C. Altered signal transduction secondary to surface IgM cross-linking on B-chronic lymphocytic leukemia cells. Differential activation of the phosphatidylinositol-specific phospholipase C. J Immunol. 144:1990;2351-2358
49. Michel F., Merle-Beral H., Legac E., Michel A., Debre P., Bismuth G. Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx. J Immunol. 150:1993;3624-3633
50. Lankester A.C., van Schijndel G.M., van der Schoot C.E., van Oers M.H., van Noesel C.J., van Lier R.A. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. Blood. 86:1995;. 1090-1071
51. Lanham S., Hamblin T., Oscier D., Ibbotson R., Stevenson F., Packham G. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood. 101:2003;1087-1093
52. Zupo S., Cutrona G., Mangiola M., Ferrarini M. Role of surface IgM and IgD on survival of the cells from B-cell chronic lymphocytic leukemia. Blood. 99:2002;2277-2278
53. Mangiola M., Cutrona G., Colombo M., Rossi E., Spriano M., Morabito F., et al. Mechanisms that control cell apoptosis or survival through surface Ig in B-CLL. Leuk Lymphoma. 44:2003;S4
54. Bernal A., Pastore R.D., Asgary Z., Keller S.A., Cesarman E., Liou H.C., et al. Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood. 98:2001;3050-3057
55. Zupo S., Massara R., Dono M., Rossi E., Malavasi F., Cosulich M.E., et al. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood. 95:2000;1199-1206
56. Dalla-Favera R., Gaidano G. Molecular Biology of Lymphomas. 2001;2215-2235 Lippincott, Philadelphia, PA
57. Jain R., Roncella S., Hashimoto S., Carbone A., Francia di Celle P., Foa R., et al. A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma. J Immunol. 153:1994;45-52
58. Roncella S., Cutrona G., Favre A., Ulivi M., Fais F., Signorini A., et al. Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen Implications for lymphomagenesis in acquired immunodeficiency syndrome. Blood. 88:1996;599-608
59. Panayiotidis P., Ganeshaguru K., Jabbar S.A., Hoffbrand A.V. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol. 85:1993;439-445
60. Pu Q.Q., Bezwoda W.R. Interleukin-4 prevents spontaneous in-vitro apoptosis in chronic lymphatic leukaemia but sensitizes B-CLL cells to melphalan cytotoxicity. Br J Haematol. 98:1997;413-417
61. Francia di Celle P., Mariani S., Riera L., Stacchini A., Reato G., Foa R. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood. 87:1996;4382-4389
62. Chaouchi N., Wallon C., Goujard C., Tertian G., Rudent A., Caput D., et al. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis. Blood. 87:1996;1022-1029
63. Trentin L., Cerutti A., Zambello R., Sancretta R., Tassinari C., Facco M., et al. Interleukin-15 promotes the growth of leukemic cells of patients with B- cell chronic lymphoproliferative disorders. Blood. 87:1996;3327-3335
64. Panayiotidis P., Jones D., Ganeshaguru K., Foroni L., Hoffbrand A.V. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol. 92:1996;97-103
65. Burger J.A., Tsukada N., Burger M., Zvaifler N.J., Dell'Aquila M., Kipps T.J. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood. 96:2000;2655-2663
66. Tsukada N., Burger J.A., Zvaifler N.J., Kipps T.J. Distinctive features of "nurselike" cells that differentiate in the context of chronic lymphocytic leukemia. Blood. 99:2002;1030-1037
67. Granziero L., Ghia P., Circosta P., Gottardi D., Strola G., Geuna M., et al. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia. Blood. 97:2001;2777-2783
68. Ibrahim S., Jilani I., O'Brien S., Rogers A., Manshouri T., Giles F., et al. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia. Cancer. 97:2003;1914-1919
69. Pizzolo G., Chilosi M., Ambrosetti A., Semenzato G., Fiore-Donati L., Perona G., et al. Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia. Blood. 62:1993;1289-1296
70. Dameshek W. Chronic lymphocytic leukemia - An accumulative disease of immunolgically incompetent lymphocytes. Blood. 29:(suppl):1967;566-584
71. Fu S.M., Winchester R.J., Feizi T., Walzer P.D., Kunkel H.G., et al. Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes. Proc Natl Acad Sci USA. 71:1974;4487-4490
72. Deegan M.J., Abraham J.P., Sawdyk M., Van Slyck E.J. High incidence of monoclonal proteins in the serum and urine of chronic lymphocytic leukemia patients. Blood. 64:1984;1207-1211
73. Qian G.X., Fu S.M., Solanki D.L., Rai K.R. Circulating monoclonal IgM proteins in B cell chronic lymphocytic leukemia Their identification, characterization and relationship to membrane IgM. J Immunol. 133:1984;3396-3400
74. Sinclair D., Dagg J.H., Mowat A.M., Parrott D.M., Stott D.I. Serum paraproteins in chronic lymphocytic leukaemia. J Clin Pathol. 37:1984;463-466
75. Fu S.M., Chiorazzi N., Kunkel H.G., Halper J.P., Harris S.R. Induction of in vitro differentiation and immunoglobulin synthesis of human leukemic B lymphocytes. J Exp Med. 148:1978;1570-1578
76. Fu S.M., Chiorazzi N., Kunkel H.G. Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia. Immunol Rev. 48:1979;23-44
77. Chiorazzi N., Fu S.M., Kunkel H.G. Induction of human antibody responses in vitro with emphasis on allogeneic helper factors. Immunol Rev. 45:1979;219-241
78. Totterman T.H., Carlsson M., Nilsson K. Induction of IgM secretion by chronic B-lymphocytic leukaemia cells in serum-free medium Effects of interferon-alpha, -gamma and phorbol ester. Clin Exp Immunol. 71:1988;187-192
79. Totterman T.H., Nilsson K., Simonsson B. Phorbol ester-induced production of beta-2-microglobulin in B-CLL cells Relation to IgM secretory response and disease activity. Br J Haematol. 62:1986;95-103
80. Rubartelli A., Sitia R., Zicca A., Grossi C.E., Ferrarini M. Differentiation of chronic lymphocytic leukemia cells correlation between the synthesis and secretion of immunoglobulins and the ultrastructure of the malignant cells. Blood. 62:1983;495-504
81. Efremov D.G., Ivanovski M., Batista F.D., Pozzato G., Burrone O.R. IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations. J Clin Invest. 98:1996;290-298
82. Fais F., Sellars B., Ghiotto F., Yan X.J., Dono M., Allen S.L., et al. Examples of in vivo isotype class switching in IgM+ chronic lymphocytic leukemia B cells. J Clin Invest. 98:1996;1659-1666
83. Dono M., Hashimoto S., Fais F., Trejo V., Allen S.L., Lichtman S.M., et al. Evidence for progenitors of chronic lymphocytic leukemia B cells that undergo intraclonal differentiation and diversification. Blood. 87:1996;1586-1594
84. Gurrieri C., McGuire P., Zan H., Yan X.-J., Cerutti A., Albesiano E., et al. Chronic lymphocytic leukemia B cells undergo somatic hypermutation and intraclonal immunoglobulin VHDJH gene diversification. J Exp Med. 196:2002;629-639
85. Honjo T., Kinoshita K., Muramatsu M. Molecular mechanism of class switch recombination linkage with somatic hypermutation. Annu Rev Immunol. 20:2002;165-196
86. Oppezzo P., Vuillier F., Vasconcelos Y., Dumas G., Magnac C., Payelle-Brogard B., et al. Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation. Blood. 101:2003;4029-4032
87. McCarthy H., Wierda W.G., Barron L.L., Cromwell C.C., Wang J., Coombes K.R., et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. Blood. 101:2003;4903-4908
88. Albesiano E., Messmer B.T., Damle R.N., Allen S.L., Rai K.R., Chiorazzi N. Activation induced cytidine deaminase in chronic lymphocytic leukemia B cells Expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood. 102:2003;3333-3339
89. Marti G.E., Zenger V., Caproaso N.E., Brown M., Washington G.C., Carter P., et al. Antigenic expression of B-cell chronic lymphocytic leukemic lymphocytes. Anal Quant Cytol Histol. 11:1989;315-323
90. Trentin L., Zambello R., Sancetta R., Facco M., Cerutti A., Perin A., et al. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res. 57:1997;4940-4947
91. Damle R.N., Ghiotto F., Valetto A., Albesiano E., Fais F., Yan X.J., et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood. 99:2002;4087-4093
92. van Oers M.H., Pals S.T., Evers L.M., van der Schoot C.E., Koopman G., Bonfrer J.M., et al. Expression and release of CD27 in human B-cell malignancies. Blood. 82:1993;3430-3436
93. Ranheim E.A., Cantwell M.J., Kipps T.J. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood. 85:1995;3556-3565
94. Bigler R.D., Bushkin Y., Chiorazzi N. S152 (CD27). A modulating disulfide-linked T cell activation antigen. J Immunol. 141:1988;21-28
95. Tangye S.G., Liu Y.J., Aversa G., Phillips J.H., de Vries J.E. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med. 188:1998;1691-1703
96. Agematsu K., Nagumo H., Yang F.C., Nakazawa T., Fukushima K., Ito S., et al. B cell subpopulations separated by CD27 and crucial collaboration of CD27+ B cells and helper T cells in immunoglobulin production. Eur J Immunol. 27:1997;2073-2079
97. Agematsu K., Nagumo H., Shinozaki K., Hokibara S., Yasui K., Terada K., et al. Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest. 102:1998;853-860
98. Freedman A.S., Freeman G., Whitman J., Segil J., Daley J., Levine H., et al. Expression and regulation of CD5 on in vitro activated human B cells. Eur J Immunol. 19:1989;849-855
99. Werner-Favre C., Vischer T.L., Wohlwend D., Zubler R.H. Cell surface antigen CD5 is a marker for activated human B cells. Eur J Immunol. 19:1989;1209-1213
100. Zupo S., Dono M., Massara R., Taborelli G., Chiorazzi N., Ferrarini M. Expression of CD5 and CD38 by human CD5- B cells requirement for special stimuli. Eur J Immunol. 24:1994;1426-1433
101. Allsopp R.C., Chang E., Kashefi-Aazam M., Rogaev E.I., Piatyszek M.A., Shay J.W., et al. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res. 220:1995;194-200
102. Nilsson P., Mehle C., Remes K., Roos G. Telomerase activity in vivo in human malignant hematopoietic cells. Oncogene. 9:1994;3043-3048
103. Broccoli D., Young J.W., de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA. 92:1995;9082-9086
104. Engelhardt M., Albanell J., Drullinsky P., Han W., Guillem J., Scher H.I., et al. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma. Clin Cancer Res. 3:1997;1849-1857
105. Damle R.N., Batliwalla F.M., Ghiotto F., Valetto A., Albesiano E., Sison C., et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. Blood. 103:2004;375-382
106. Hultdin M., Rosenquist R., Thunberg U., Tobin G., Norrback K.F., Johnson A., et al. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia Clinical and biological implications. Br J Cancer. 88:2003;593-598
107. Montserrat E., Sanchez-Bisono J., Vinolas N., Rozman C. Lymphocyte doubling time in chronic lymphocytic leukaemia analysis of its prognostic significance. Br J Haematol. 62:1986;567-575
108. Neese R.A., Siler S.Q., Cesar D., Antelo F., Lee D., Misell L., et al. Advances in the stable isotope-mass spectrometric measurement of DNA synthesis and cell proliferation. Anal Biochem. 298:2001;189-195
109. Messmer D., Messmer B., Albesiano E., Damle R., Allen S.L., Kudalkar P., et al. Direct measurement of B-CLL cell production and turnover in vivo. Blood. 100:2002;169a. (abstr)
110. Dohner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bullinger L., et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 343:2002;1910-1916
111. Stilgenbauer S., Lichter P., Dohner H. Genomic aberrations in B cell chronic lymphocytic leukemia. Cheson B.D. Chronic Lymphoid Leukemias. 2001;353-376 Dekker, New York, NY
112. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 99:2002;15524-15529
113. Oscier D.G., Thompsett A., Zhu D., Stevenson F.K. Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood. 89:1997;4153-4160
114. Desmaze C., Soria J.C., Freulet M.A.-Marriere, Mathieu N., Sabatier L. Telomere-driven genomic instability in cancer cells. Cancer Lett. 194:2003;173-182
115. Malisan F., Fluckiger A.C., Ho S., Guret C., Banchereau J., Martinez-Valdez H. B-chronic lymphocytic leukemias can undergo isotype switching in vivo and can be induced to differentiate and switch in vitro. Blood. 87:1996;717-724
116. Bentz M., Huck K., du Manoir S., Joos S., Werner C.A., Fischer K., et al. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood. 85:1995;3610-3618
117. Novak U., Oppliger Leibundgut E., Hager J., Muhlematter D., Jotterand M., Besse C., et al. A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL). Blood. 100:2002;1787-1794
118. Ottaggio L., Viaggi S., Zunino A., Zupo S., Rossi E., Spriano M., et al. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia Correlation with CD38 expression. Haematologica. 88:2003;769-777
119. Kuppers R., Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 20:2001;5580-5594
120. Mann D.L., DeSantis P., Mark G., Pfeifer A., Newman M., Gibbs N., et al. HTLV-I-associated B-cell CLL Indirect role for retrovirus in leukemogenesis. Science. 236:1987;1103-1106
121. Liu Y.J., Johnson G.D., Gordon J., MacLennan I.C. Germinal centres in T-cell-dependent antibody responses. Immunol Today. 13:1992;17-21
122. Hardy R.R., Hayakawa K. B cell development pathways. Annu Rev Immunol. 19:2001;595-621
123. Klein U., Goossens T., Fischer M., Kanzler H., Braeuninger A., Rajewsky K., et al. Somatic hypermutation in normal and transformed human B cells. Immunol Rev. 162:1988;261-280
124. Spencer J., Perry M.E., Dunn-Walters D.K. Human marginal-zone B cells. Immunol Today. 19:1998;421-426
125. Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 14:2001;617-629
126. Martin F., Kearney J.F. Marginal-zone B cells. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Nat Rev Immunol. 2:2002;323-335
127. Chen X., Martin F., Forbush K.A., Perlmutter R.M., Kearney J.F. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol. 9:1997;27-41
128. Dono M., Zupo S., Leanza N., Melioli G., Fogli M., Melagrana A., et al. Heterogeneity of tonsillar subepithelial B lymphocytes, the splenic marginal zone equivalents. J Immunol. 164:2000;5596-5604
129. Dono M., Zupo S., Colombo M., Massara R., Gaidano G.L., Taborelli G., et al. The human marginal zone B cell. Ann NY Acad Sci. 987:2003;117-124
130. Fagarasan S., Honjo T. Intestinal IgA synthesis Regulation of front-line body defences. Nat Rev Immunol. 3:2003;63-72
131. Liu Y.J., Barthelemy C., de Bouteiller O., Arpin C., Durand I., Banchereau J. Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity. 2:1995;239-248
132. Kantor A.B., Stall A.M., Adams S., Herzenberg L.A., Herzenberg L.A. Differential development of progenitor activity for three B-cell lineages. Proc Natl Acad Sci USA. 89:1992;3320-3324
133. Nisitani S., Murakami M., Akamizu T., Okino T., Ohmori K., Mori T., et al. Preferential localization of human CD5+ B cells in the peritoneal cavity. Scand J Immunol. 46:1997;541-545
134. Dammers P.M., Visser A., Popa E.R., Nieuwenhuis P., Kroese F.G. Most marginal zone B cells in rat express germline encoded Ig VH genes and are ligand selected. J Immunol. 165:2000;6156-6169
135. Li Y., Li H., Weigert M. Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med. 195:2002;181-188
136. Widhopf G.F. 2nd, Brinson D.C., Kipps T.J., Tighe H. Transgenic expression of a human polyreactive Ig expressed in chronic lymphocytic leukemia generates memory-type B cells that respond to nonspecific immune activation. J Immunol. 172:2004;2092-2099
137. Seidl K.J., MacKenzie J.D., Wang D., Kantor A.B., Kabat E.A., Herzenberg L.A. Frequent occurrence of identical heavy and light chain Ig rearrangements. Int Immunol. 9:1997;689-702
138. Messmer B.T., Albesiano E., Messmer D., Chiorazzi N. The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia are consistent with the canonical somatic hypermutation process. Blood. 103:2004;3490-3495
139. Zelenetz A.D., Chen T.T., Levy R. Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection. J Exp Med. 176:1992;1137-1148
140. Capello D., Fais F., Vivenza D., Migliaretti G., Chiorazzi N., Gaidano G., et al. Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes. Leukemia. 14:2000;811-815
141. Pasqualucci L., Neri A., Baldini L., Dalla-Favera R., Migliazza A. BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 60:2000;5644-5648
142. Sahota S.S., Davis Z., Hamblin T.J., Stevenson F.K. Somatic mutation of bcl-6 genes can occur in the absence of V(H) mutations in chronic lymphocytic leukemia. Blood. 95:2000;3534-3540
143. Klein U., Tu Y., Stolovitzky G.A., Mattioli M., Cattoretti G., Husson H., Freedman A., et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 194:2001;1625-1638
144. Wakai M., Hashimoto S., Omata M., Sthoeger Z.M., Allen S.L., Lichtman S.M., et al. IgG+, CD5+ human chronic lymphocytic leukemia B cells. Production of IgG antibodies that exhibit diminished autoreactivity and IgG subclass skewing. Autoimmunity. 19:1994;39-48
145. Hashimoto S., Dono M., Wakai M., Allen S.L., Lichtman S.M., Schulman P., et al. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med. 181:1995;1507-1517
146. Casola S., Otipoby K.L., Alimzhanov M., Humme S., Uyttersprot N., Kutok J.L., et al. B cell receptor signal strength determines B cell fate. Nat Immunol. 5:2004;317-327
147. Ikematsu H., Kasaian M.T., Schettino E.W., Casali P. Structural analysis of the VH-D-JH segments of human polyreactive IgG mAb. Evidence for somatic selection. J Immunol. 151:1993;3604-3616
148. Rawstron A.C., Green M.J., Kuzmicki A., Kennedy B., Fenton J.A., Evans P.A., et al. Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 100:2002;635-639
149. Ghia P., Prato G., Scielzo C., Stella S., Geuna M., Guida G., et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood. 103:2004;2337-2342
150. Rawstron A.C., Yuille M.R., Fuller J., Cullen M., Kennedy B., Richards S.J., et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood. 100:2002;2289-2290
151. Kipps T.J. The CD5 B cell. Adv Immunol. 47:1989;117-185
152. Dono M., Zupo S., Burgio V.L., Augliera A., Tacchetti C., Favre A., et al. Phenotypic and functional characterization of human tonsillar subepithelial (SE) B cells. Ann N Y Acad Sci. 815:1997;171-181
153. Dono M., Zupo S., Massara R., Ferrini S., Melagrana A., Chiorazzi N., et al. In vitro stimulation of human tonsillar subepithelial B cells Requirement for interaction with activated T cells. Eur J Immunol. 31:2001;752-756
154. Dono M., Zupo S., Grossi C.E., Chiorazzi N., Ferrarini M. Subepithelial B cells of the human tonsil. Chem Immunol. 67:1997;58-69
155. Ghia P., Caligaris-Cappio F. The indispensable role of microenvironment in the natural history of low-grade B-cell neoplasms. Adv Cancer Res. 79:2000;157-173